Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHIMAZOLE for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 9 adverse event reports in the FDA FAERS database where METHIMAZOLE was used for Atrial fibrillation.

Most Reported Side Effects for METHIMAZOLE

Side Effect Reports % Deaths Hosp.
Drug ineffective 305 12.2% 18 185
Agranulocytosis 263 10.5% 36 199
Hyperthyroidism 206 8.2% 9 105
Off label use 143 5.7% 6 62
Hypothyroidism 98 3.9% 3 36
Foetal exposure during pregnancy 85 3.4% 7 19
Neutropenia 78 3.1% 5 42
Condition aggravated 76 3.0% 7 36
Thyrotoxic crisis 75 3.0% 6 53
Drug-induced liver injury 73 2.9% 6 36
Product use in unapproved indication 67 2.7% 3 20
Exposure during pregnancy 63 2.5% 0 13
Product use issue 63 2.5% 3 19
Pruritus 63 2.5% 13 22
Rash 62 2.5% 2 19

Other Indications for METHIMAZOLE

Hyperthyroidism (897) Basedow's disease (432) Product used for unknown indication (359) Graves' disease (263) Thyrotoxic crisis (109) Thyroid disorder (49) Hypothyroidism (24) Goitre (15) Endocrine ophthalmopathy (14) Thyroiditis (13)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

METHIMAZOLE Full Profile All Atrial fibrillation Drugs METHIMAZOLE Demographics METHIMAZOLE Timeline